Download PDF
Thromb Haemost 2010; 104(01): 122-127
DOI: 10.1160/TH09-12-0837
Cardiovascular Biology and Cell Signalling
Schattauer GmbH

Characterisation and validity of inflammatory biomarkers in the prediction of post-operative atrial fibrillation in coronary artery disease patients

Diana Kaireviciute
1   Haemostasis, Thrombosis, and Vascular Biology Unit, University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom
2   Vilnius University Hospital Santariskiu Klinikos, Vilnius, Lithuania
,
Andrew D. Blann
1   Haemostasis, Thrombosis, and Vascular Biology Unit, University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom
,
Balu Balakrishnan
1   Haemostasis, Thrombosis, and Vascular Biology Unit, University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom
,
Deirdre A. Lane
1   Haemostasis, Thrombosis, and Vascular Biology Unit, University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom
,
Jeetesh V. Patel
1   Haemostasis, Thrombosis, and Vascular Biology Unit, University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom
,
Giedrius Uzdavinys
2   Vilnius University Hospital Santariskiu Klinikos, Vilnius, Lithuania
3   University of Vilnius, Vilnius, Lithuania
,
Gediminas Norkunas
2   Vilnius University Hospital Santariskiu Klinikos, Vilnius, Lithuania
3   University of Vilnius, Vilnius, Lithuania
,
Gintaras Kalinauskas
2   Vilnius University Hospital Santariskiu Klinikos, Vilnius, Lithuania
3   University of Vilnius, Vilnius, Lithuania
,
Vytautas Sirvydis
2   Vilnius University Hospital Santariskiu Klinikos, Vilnius, Lithuania
3   University of Vilnius, Vilnius, Lithuania
,
Audrius Aidietis
2   Vilnius University Hospital Santariskiu Klinikos, Vilnius, Lithuania
3   University of Vilnius, Vilnius, Lithuania
,
Gregory Y. H. Lip
1   Haemostasis, Thrombosis, and Vascular Biology Unit, University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom
› Author Affiliations
Financial support: This work is supported by a research fellowship awarded by the European Society of Cardiology to Dr Diana Kaireviciute, and has been presented in abstract form during the ESC Congress in Munich, Germany, 2008.
Further Information

Publication History

Received: 13 December 2009

Accepted after minor revision: 09 February 2010

Publication Date:
23 November 2017 (online)

 PDF Download  Permissions and Reprints

Summary

Atrial fibrillation (AF) is a common complication of coronary artery bypass grafting (CABG). We sought to determine the diagnostic validity of plasma biomarkers of i) inflammation (marked by interleukin-6 [IL-6] and high-sensitivity C-reactive protein [hs-CRP]), ii) extracellular matrix remodelling (matrix metalloproteinase [MMP-9], tissue inhibitor of matrix metalloproteinase [TIMP-1]) and iii) the prothrombotic state (tissue factor and von Willebrand factor [vWF]) in the risk prediction of post-operative AF. Samples were obtained preoperatively from peripheral/femoral vein and from intracardiac chambers (right atrium [RA], the right atrial appendage [RAA], the left atrium [LA] and the left atrial appendage [LAA]) amongst 100 consecutive patients free of AF and inflammatory disease undergoing elective CABG. Biomarker concentrations were related to incident AF (30 days). At 30 days post CABG, 30 patients were proven to have had AF. Concentrations of tissue factor (TF) and vWF were unrelated to postoperative AF. Peripheral (p=0.018), and intracardiac levels (RAA (p=0.029) and LA (p=0.026)) of hs-CRP were associated with the presence of AF after CABG. Intracardiac levels of IL-6 in samples from the RAA (p=0.031), LA (p=0.042) and LAA (p=0.006), and MMP-9 in the LAA sample were also associated with AF (p=0.007). Our data suggest that an intra-cardiac inflammatory environment that is manifest peri-operatively may predispose to the development of post-operative AF. This intracardiac inflammatory state was reflected by increased peripheral hs-CRP levels. These differences may indicate local substrate abnormalities contributing to the development of AF post-operatively.

Keywords

Atrial fibrillation - inflammation - prothrombotic state - remodeling - cardiac surgery
 

  • References

  • 1 Lauer MS, Eagle KA, Buckley MJ. et al Atrial fibrillation following coronary artery bypass surgery. Prog Cardiovasc Dis 1989; 05: 367-368.
    PubMedSearch in Google Scholar
  • 2 White HD, Antman EM, Glynn MA. et al Efficacy and safety of timolol for the prevention of supraventricular arrhythmias after coronary artery bypass surgery. Circulation 1984; 70: 479-484.
    CrossrefPubMedSearch in Google Scholar
  • 3 Andrews TC, Reimold SC, Berlin JA. et al Prevention of supraventricular arrhythmias after coronary artery bypass surgery. A meta-analysis of randomized control trials. Circulation 1991; 84 III 236-244.
    PubMedSearch in Google Scholar
  • 4 Mathew JP, Fontes ML, Tudor IC. et al A multicenter risk index for atrial fibrillation after cardiac surgery. J Am Med Assoc 2004; 291: 1720-1729.
    CrossrefPubMedSearch in Google Scholar
  • 5 Aranki SF, Shaw DP, Adams DH. et al Predictors for atrial fibrillation after coronary artery surgery. Circulation 1996; 94: 390-397.
    CrossrefPubMedSearch in Google Scholar
  • 6 Stamou SC, Dangas G, Hill PC. et al Atrial fibrillation after beating heart surgery. Am J Cardiol 2000; 86: 64-67.
    CrossrefPubMedSearch in Google Scholar
  • 7 Villareal RP, Hariharan R, Liu BC. et al Postoperative atrial fibrillation and mortality after coronary artery bypass surgery. J Am Coll Cardiol 2004; 43: 742-748.
    CrossrefPubMedSearch in Google Scholar
  • 8 Ahmadi H, Karimi A, Davoodi S. et al 24-hour in-hospital mortality predictions in coronary artery bypass grafting patients. Arch Med Res 2007; 38: 417-423.
    CrossrefPubMedSearch in Google Scholar
  • 9 Likosky DS, Leavitt BJ, Marrin CAS. et al Intra- and postoperative predictors of stroke after coronary artery bypass grafting. Ann Thorac Surg 2003; 76: 428-435.
    CrossrefPubMedSearch in Google Scholar
  • 10 Borzak S, Tisdale JE, Amin NB. et al Atrial fibrillation after bypass surgery: does the arrhythmia or the characteristics of the patients prolong hospital stay?. Chest 1998; 113: 1489-1491.
    CrossrefPubMedSearch in Google Scholar
  • 11 Chung MK, Martin DO, Sprecher D. et al C-reactive protein elevation in patients with atrial arrhythmias. Inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001; 104: 2886-2891.
    CrossrefPubMedSearch in Google Scholar
  • 12 Psychari SN, Apostolou TS, Sinos L. et al Relation of elevated C-reactive protein and interleukin-6 levels to atrial size and duration of episodes in patients with atrial fibrillation. Am J Cardiol 2005; 95: 764-767.
    CrossrefPubMedSearch in Google Scholar
  • 13 Aviles RJ, Martin DO, Apperson-Hansen C. et al Inflammation as a risk factor for atrial fibrillation. Circulation 2003; 108: 3006-3010.
    CrossrefPubMedSearch in Google Scholar
  • 14 Chen CL, Huang SK, Lin JL. et al Upregulation of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases in rapid atrial pacing-induced atrial fibrillation. J Mol Cell Cardiol 2008; 45: 742-753.
    CrossrefPubMedSearch in Google Scholar
  • 15 Nakano Y, Niida S, Dote K. et al Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation. J Am Coll Cardiol 2004; 43: 818-825.
    CrossrefPubMedSearch in Google Scholar
  • 16 Conway DS, Buggins P, Hughes E. et al Prognostic significance of raised plasma levels of IL-6 and C-reactive protein in atrial fibrillation. Am Heart J 2004; 148: 462-466.
    CrossrefPubMedSearch in Google Scholar
  • 17 Thambidorai SK, Parakh K, Martin DO. et al Relation of C-reactive protein correlates with risk of thromboembolism in patients with atrial fibrillation. Am J Cardiol 2004; 94: 805-807.
    CrossrefPubMedSearch in Google Scholar
  • 18 Kirchhof P, Bax J, Blomstrom-Lundquist C. et al Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'. Eur Heart J 2009; 30: 2969-2977c.
    CrossrefPubMedSearch in Google Scholar
  • 19 Edmunds Jr LH. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1998; 66: S12-S16.
    CrossrefPubMedSearch in Google Scholar
  • 20 Corbi P, Rahmati M, Delwai A. et al Circulating soluble gp130, soluble IL-6R, and IL-6 in patients undergoing cardiac surgery, with or without extracorporeal circulation. Eur J Cardiothorac Surg 2000; 18: 98-103.
    CrossrefPubMedSearch in Google Scholar
  • 21 Lo B, Fijnheer R, Nierich AP. et al C-reactive protein is a risk indicator for atrial fibrillation after myocardial revascularization. Ann Thorac Surg 2005; 79: 1530-1535.
    CrossrefPubMedSearch in Google Scholar
  • 22 Ucar I H, Tok M, Atalar E, Dogan OF. et al Predictive significance of plasma levels of interleukin-6 and high-sensitivity C-reactive protein in atrial fibrillation after coronary artery bypass surgery. Heart Surg Forum 2007; 10: E131-135.
    CrossrefPubMedSearch in Google Scholar
  • 23 Fontes ML, Mathew JP, Rinder HM. et al. and the Multicenter Study of Perioperative Ischemia (McSPI) Reasearch Group. Atrial fibrillation after cardiac surgery/cardiopulmonary bypass is associated with monocyte activation. Anesth Analg 2005; 101: 17-23.
    CrossrefPubMedSearch in Google Scholar
  • 24 Ahlsson AJ, Bodin L, Lundblad OH. et al Postoperative atrial fibrillation is not correlated to C-reactive protein. Ann Thorac Surg 2007; 83: 1332-1337.
    CrossrefPubMedSearch in Google Scholar
  • 25 Danesh J, Whincup P, Walker M. et al Low grade inflammation and coronary heart. Br Med J 2000; 321: 199-204.
    CrossrefPubMedSearch in Google Scholar
  • 26 Ak K, Akgun S, Tecimer T. et al Determination of histopathologic risk factors for postoperative atrial fibrillation in cardiac surgery. Ann Thorac Surg 2005; 79: 1970-1975.
    CrossrefPubMedSearch in Google Scholar
  • 27 Mariscalco G, Engstrom KG, Ferrareze S. et al Relationship between atrial histopathology and atrial fibrillation after coronary bypass surgery. J Thorac Cardiovasc Surg 2006; 131: 1364-1372.
    CrossrefPubMedSearch in Google Scholar
  • 28 Nakai T, Chandy J, Nakai K. et al Histologic assessment of right atrial appendage myocardium in patients with atrial fibrillation after coronary artery bypass graft surgery. Cardiology 2007; 108: 90-96.
    CrossrefPubMedSearch in Google Scholar
  • 29 Brauer PR. MMPs – role in cardiovascular development and disease. Front Biosci 2006; 11: 447-478.
    CrossrefPubMedSearch in Google Scholar
  • 30 Mukherjee R, Herron AR, Lowry AS. et al Selective induction of matrix metalloproteinases and tissue inhibitor of metalloproteinases in atrial and ventricular myocardium in patients with atrial fibrillation. Am J Cardiol 2006; 97: 532-537.
    CrossrefPubMedSearch in Google Scholar
  • 31 Gramley F, Lorenzen J, Plisiene J. et al. Decreased plasminogen activator inhibitor and tissue metalloproteinase inhibitor expression may promote increased metalloproteinase activity with increasing duration of human atrial fibrillation. J Cardiovasc Electrophysiol 2007; 18: 1076-82.
    CrossrefPubMedSearch in Google Scholar
  • 32 Blann AD. Plasma von Willebrand factor, thrombosis, and the endothelium: the first 30 years. Thromb Haemost 2006; 95: 49-55.
    Thieme ConnectPubMedSearch in Google Scholar
  • 33 Mondillo S, Sabatini L, Agricola E. et al Correlation between left atrial size, pro-thrombotic state and markers of endothelial dysfunction in patients with lone chronic non-rheumatic atrial fibrillation. Int J Cardiol 2000; 75: 227-232.
    CrossrefPubMedSearch in Google Scholar
  • 34 Freestone B, Chong AY, Nuttall S. et al Soluble E-selectin, von Willebrand factor, soluble thrombomodulin, and total body nitrate/nitrite product as indices of endothelial damage/dysfunction in paroxysmal, persistent, and permanent atrial fibrillation. Chest 2007; 132: 1253-1258.
    CrossrefPubMedSearch in Google Scholar
  • 35 Roldán V, Marin F, Blann AD. et al Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation. Eur Heart J 2003; 24: 1373-1380.
    CrossrefPubMedSearch in Google Scholar
  • 36 Chung NA, Belgore F, Li-Saw-Hee FL. et al Is the hypercoagulable state in atrial fibrillation mediated by vascular endothelial growth factor?. Stroke 2002; 33: 2187-2191.
    CrossrefPubMedSearch in Google Scholar
  • 37 Goldsmith I, Kumar P, Carter P. et al Atrial endocardial changes in mitral valve disease: A scanning electron microscopy study. Am Heart J 2000; 140: 777-784.
    CrossrefPubMedSearch in Google Scholar
  • 38 Boyaci A, Topaloglu S, Yilmaz S. et al Regional left atrial coagulation and fibrinolytic activities in patients with mitral stenosis. Jpn Heart J 2004; 45: 779-788.
    CrossrefPubMedSearch in Google Scholar
  • 39 Li-Saw-Hee FL, Blann AD, Goldsmith I. et al Indexes of hypercoagulability measured in peripheral blood reflect levels in intracardiac blood in patients with atrial fibrillation secondary to mitral stenosis. Am J Cardiol 1999; 83: 1206-1209.
    CrossrefPubMedSearch in Google Scholar
  • 40 Prasongsukarn K, Abel JG, Jamieson WR. et al The effects of steroids on the occurrence of postoperative atrial fibrillation after coronary artery bypass grafting surgery: a prospective randomized trial. J Thorac Cardiovasc Surg 2005; 130: 93-98.
    Thieme ConnectPubMedSearch in Google Scholar
  • 41 Carnes CA, Chung MK, Nakayama T. et al Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation. Circ Res 2001; 89: E32-38.
    CrossrefPubMedSearch in Google Scholar
  • 42 Calò L, Bianconi L, Colivicchi F. et al N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. J Am Coll Cardiol 2005; 45: 1723-1728.
    CrossrefPubMedSearch in Google Scholar
  • 43 Patti G, Chello M, Candura D. et al Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study. Circulation 2006; 114: 1455-1461.
    CrossrefPubMedSearch in Google Scholar